Literature DB >> 11846972

IRF and tuberculosis.

Richard Pine1.   

Abstract

Tuberculosis is the most prevalent infectious disease and causes more deaths than any other, yet only 5%-10% of people infected by the causative agent, Mycobacterium tuberculosis, will develop the disease. Thus, natural resistance among humans is the norm. Fundamental immune responses to M. tuberculosis are being elucidated, including induction of interferon regulatory factor-1 (IRF-1). Moreover, IRF-1 has been found necessary for normal resistance to infection by mycobacteria in mice. Roles for IRF-1 in a plethora of immune system functions have been described. This review considers molecular responses to infection by M. tuberculosis that might account for induction of IRF-1 and highlights putative connections between immunomodulatory functions of IRF-1 and immune responses relevant to infection by M. tuberculosis. However, the complexity inherent in pleiotropy and redundancy limits the ability to draw firm conclusions. In many cases, it remains to be demonstrated that a particular function of IRF-1 is the basis for a known response to infection. For example, although IRF-1 is required for a Th1 cell-mediated, adaptive immune response in some circumstances, it is not known if the Th1 response to infection by M. tuberculosis requires IRF-1. Conversely, some known contributions by IRF-1 to fundamental aspects of the immune system are not yet proven relevant in the host response to infection. For example, it is not known if control of T cell subset development by IRF-1 is significant for host defense against M. tuberculosis. Functions of other IRF that overlap with or are distinct from the functions of IRF-1 also could be important for the immune response to M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846972     DOI: 10.1089/107999002753452629

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

1.  No significant impact of IFN-γ pathway gene variants on tuberculosis susceptibility in a West African population.

Authors:  Christian G Meyer; Christopher D Intemann; Birgit Förster; Ellis Owusu-Dabo; Andre Franke; Rolf D Horstmann; Thorsten Thye
Journal:  Eur J Hum Genet       Date:  2015-08-05       Impact factor: 4.246

2.  Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide.

Authors:  Kristin R Morris; Ryan D Lutz; Hyung-Seok Choi; Tetsu Kamitani; Kathryn Chmura; Edward D Chan
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

3.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

4.  Fine-tuning of macrophage activation using synthetic rocaglate derivatives.

Authors:  Bidisha Bhattacharya; Sujoy Chatterjee; William G Devine; Lester Kobzik; Aaron B Beeler; John A Porco; Igor Kramnik
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379

Review 5.  Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease.

Authors:  Aleksandra Antonczyk; Bart Krist; Malgorzata Sajek; Agata Michalska; Anna Piaszyk-Borychowska; Martyna Plens-Galaska; Joanna Wesoly; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

6.  Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.

Authors:  Vanessa Daza-Cajigal; Adriana S Albuquerque; Dan F Young; Michael J Ciancanelli; Dale Moulding; Ivan Angulo; Valentine Jeanne-Julien; Jérémie Rosain; Ekaterina Minskaia; Jean-Laurent Casanova; Stéphanie Boisson-Dupuis; Jacinta Bustamante; Richard E Randall; Timothy D McHugh; Adrian J Thrasher; Siobhan O Burns
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

7.  Recombinant Mtb9.8 of Mycobacterium bovis stimulates TNF-α and IL-1β secretion by RAW264.7 macrophages through activation of NF-κB pathway via TLR2.

Authors:  Shuqing Liu; Hong Jia; Shaohua Hou; Ting Xin; Xiaoyu Guo; Gaimei Zhang; Xintao Gao; Ming Li; Wuyang Zhu; Hongfei Zhu
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.